|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
(none)
|
|
INDICATIONS:
|
|
Nutrition, supplement |
|
Pregnancy, adjunct |
| |
|
|
SIDE EFFECTS:
|
|
anorexia |
|
AV block |
|
cardiac arrest |
|
confusion |
|
constipation |
|
dizziness |
|
drowsiness |
|
flushing |
|
hypercalcemia |
|
hypertension |
|
hypotension |
|
injection site reaction |
|
milk-alkali syndrome |
|
nausea/vomiting |
|
nephrolithiasis |
|
polyuria |
|
premature ventricular contractions (PVCs) |
|
pruritus |
|
sinus bradycardia |
|
syncope |
|
tissue necrosis |
|
ventricular fibrillation |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
breast-feeding |
|
cardiac arrhythmias |
|
dehydration |
|
diarrhea |
|
hyperphosphatemia |
|
hypoparathyroidism |
|
pregnancy |
|
sarcoidosis |
|
ventricular fibrillation |
|
|
ADULT DOSE:
|
|
Hypocalcemia (prophylaxis)-Oral, amount based on normal daily recommended intakes:
Persons U.S. Canada
(mg) (mg)
Adolescent and adult males 800-1200 800-1100
Adolescent and adult females 800-1200 700-1100
Pregnant females 1200 1200-1500
Breast-feeding females 1200 1200-1500
Hypocalcemia (treatment)-Treatment dose is individualized by prescriber based on severity of deficiency. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Hypocalcemia (prophylaxis)-Oral, amount based on normal daily recommended intakes:
Persons U.S. Canada
(mg) (mg)
Infants and children 400-800 250-550
Birth to 3 years of age
4 to 6 years of age 800 600
7 to 10 years 800 700-1100
Hypocalcemia (treatment)-Treatment dose is individualized by prescriber based on severity of deficiency. |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|